Archive readyExternal timestamp ready

ブライトパス・バイオ株式会社

https://www.brightpathbio.com/

April 22, 2026 at 01:28 AM JST•The archive page, viewer, and downloads use this saved version.

April 22, 2026 at 01:28 AM JST·www.brightpathbio.com

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

External timestamp

The evidence pack includes the third-party timestamp files.

External timestamp

External timestamp ready

Provider

DigiCert RFC3161

TSA time

April 22, 2026 at 01:31 AM JST

Saved page

ブライトパス・バイオ株式会社

Open the archived HTML with saved-time metadata attached.

Original URLhttps://www.brightpathbio.com/

StartedApril 22, 2026 at 01:28 AM JST

This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.

About this pageAI generated

This page is the official website of BrightPath Biotherapeutics Co., Ltd., a company developing cancer immunotherapy based on iPS cell technology. The company's core technology is iPS-NKT, a novel allogeneic cancer immune cell therapeutic derived from NKT cells. The pipeline includes cell therapy, antibody therapeutics, and cancer vaccines. The site provides company information, technology details, development pipeline, news, and investor relations information. Recent news covers clinical trial timelines and financial forecasts.

Screenshot

The full page can be captured up to 15,000px in height so you can review the complete page layout when needed.